If you drink from a private well, live near old mining or milling sites, or work in nuclear, fertilizer, or mining industries, you may be carrying more uranium in your body than you realize. The metal slips into the body through water and food, accumulates in the kidneys, and can damage how they filter waste long before standard kidney tests show anything wrong.
This test measures how much uranium your body has absorbed and is currently excreting. It is the cleanest signal available for a quiet, ongoing exposure that a routine metabolic panel will not catch.
This urine test quantifies uranium, a heavy metal that occurs naturally in soil, rock, and groundwater. Urinary uranium is the biomarker of choice for exposure assessment because the kidney is the main route of excretion. A single urine sample reflects roughly the previous two weeks of exposure, and when intake is fairly steady, one spot result can serve as a reasonable indicator of chronic exposure.
Whole blood is not a reliable matrix for uranium exposure, even though it works for several other metals. A normal blood reading can coexist with meaningful exposure visible only in urine. This is why a generic heavy-metal blood panel can give a misleading sense of safety if uranium is the metal you actually need to track.
For most people, uranium enters the body through drinking water and diet, with inhalation becoming the dominant route in occupational settings such as mining, milling, nuclear fuel work, and phosphate fertilizer production. Groundwater near natural mineralization or near current and former uranium mines can carry concentrations that exceed drinking-water limits by orders of magnitude. Private wells are a particular concern because they are not regulated the way municipal systems are.
In one analysis of US adults, both unregulated private wells and regulated community water systems contributed measurably to urinary uranium levels, even at concentrations below current regulatory standards. Background biomonitoring values also vary widely by country: a Serbian study reported blood uranium levels up to 100-fold higher than in some other populations, showing how much geography matters.
The kidneys are the organ most at risk from uranium exposure, and that is where the strongest human evidence sits. In a study of 88,185 California women, long-term exposure to uranium in community drinking water was associated with about a 30% greater risk of developing chronic kidney disease. This signal showed up at exposures within community water systems, not just in clearly contaminated areas.
In animal models of repeated uranium exposure, the threshold for measurable kidney injury was identified between 0.25 and 1 mg per kilogram of body weight per day, and altered kidney handling of uranium changed how it was excreted. Human epidemiologic findings on kidney function are more mixed. A systematic review and meta-analysis of uranium-exposed individuals found trends toward slightly worse kidney function biomarkers but did not reach statistical significance, and mortality from kidney cancer or chronic nephritis was not elevated. The most credible read is that long-term exposure raises chronic kidney disease risk in the population, while individual mortality from rare kidney outcomes is harder to detect.
You will see two findings that look like they disagree: long-term water exposure clearly raises chronic kidney disease risk, while occupational cohorts often show no increased mortality from kidney cancer or chronic nephritis. Both can be true. Worker cohorts are filtered by the healthy-worker effect (people sick enough to die early often leave the workforce), and they study a different exposure pattern (intermittent inhalation of particulates) than community drinking water (steady, low-dose oral intake over decades). The kidney injury that shows up first is functional decline, captured in CKD risk, not death from a rare cancer.
Uranium is now showing up in cardiovascular research as well. In the Strong Heart Family Study of 1,453 American Indian adults, higher uranium exposure was associated with greater risk of high blood pressure. In the Multi-Ethnic Study of Atherosclerosis, which followed 6,599 adults, urinary metal levels including uranium were linked to higher risk of cardiovascular disease and all-cause mortality.
In a long-term follow-up of 6,403 uranium processing workers at the Fernald plant from 1951 to 1985, increased internal uranium exposure was associated with greater risk of cardiovascular disease, with smoking as a possible confounder. The mechanism is not fully understood, but the pattern is consistent enough across cohorts that uranium should be considered when looking for hidden drivers of vascular risk.
Most of the cancer signal in uranium-exposed workers traces to radon, a radioactive gas released during mining, rather than to uranium itself. The updated French uranium miners cohort of 8,463 workers and the Ontario miners cohort both showed elevated lung cancer risk tied to cumulative radon exposure. The Colorado Plateau miner cohort of 4,137 workers found a greater-than-additive interaction between radon and smoking for lung cancer mortality.
For uranium itself, evidence in workers points to dose-related risks for kidney cancer and multiple myeloma in gaseous diffusion plant employees, with mortality also tracking internally deposited uranium dose. These are findings from heavily exposed occupational cohorts, not the general population, and they should not be read as a direct estimate of cancer risk for someone with mildly elevated water-based exposure.
Uranium is best understood as a research and exposure-biomonitoring marker rather than a fully standardized clinical test. There are no universally agreed clinical cutpoints, only population reference values from biomonitoring surveys. The numbers below come from a US biomonitoring study of 500 residents and a Swiss study of 1,393 adults using 24-hour urine collections, both measured by mass spectrometry (a sensitive lab method for measuring trace metals). They are illustrative orientation, not clinical targets, and your lab may report different numbers and units.
| Tier | Range | What It Suggests |
|---|---|---|
| Typical low background | Around 34.5 to several hundred nanograms per liter (US reference) | Consistent with general population exposure |
| Upper end of population reference | Up to roughly 4,080 nanograms per liter (US 95th percentile range) | Higher than most peers; worth investigating exposure sources |
| Occupational concern threshold | Above 15 micrograms per liter (proposed in occupational guidance) | Concentration historically flagged as a kidney-toxicity concern in uranium workers |
Compare your results within the same lab over time for the most meaningful trend. A single value sitting near the lower end of normal is not as informative as a series of readings that show whether your exposure is rising, falling, or stable.
Uranium intake is rarely a one-time event. It is usually steady, tied to what you drink and where you live. Because of this, a single result tells you about the past two weeks; a series tells you whether your everyday environment is adding to your body burden. If your baseline is elevated, retest in 3 to 6 months after changing your water source or filtration setup, then at least annually if you live in a higher-risk area. If your initial reading is low and your exposures have not changed, an annual check is reasonable.
Within-lab trending matters more than chasing a specific number. Different assays and matrices produce different absolute values, but a doubling of your urinary uranium on the same lab over six months is meaningful regardless of where it sits in a population reference range.
If your urinary uranium is elevated, treat it as a prompt to find the source rather than a diagnosis on its own. Start by testing your drinking water (especially private well water) for uranium and other heavy metals, and review any occupational or hobby exposures that involve mining, milling, nuclear, or fertilizer materials. Pair retesting with a kidney function workup that includes serum creatinine, cystatin C, eGFR, and urine albumin-to-creatinine ratio. In a research setting, kidney tubule injury biomarkers (proteins released when the small filtering tubes inside the kidney are stressed, evaluated in the Multi-Ethnic Study of Atherosclerosis) have shown sensitivity to uranium-related kidney stress.
Persistently elevated urinary uranium combined with rising creatinine, falling eGFR, or new albuminuria warrants involving a nephrologist familiar with environmental nephrology. Pattern over time matters more than any single value: a stable mid-range result with normal kidney markers is much less concerning than a rising trend paired with early kidney signals.
Evidence-backed interventions that affect your Uranium 24 Hour level
Uranium 24 Hour is best interpreted alongside these tests.